Cizzle Biotechnology Holdings Plc (LON:CIZ – Get Free Report) was down 14.6% during mid-day trading on Monday . The company traded as low as GBX 1.26 ($0.02) and last traded at GBX 1.26 ($0.02). Approximately 400,000 shares changed hands during mid-day trading, a decline of 70% from the average daily volume of 1,329,828 shares. The stock had previously closed at GBX 1.48 ($0.02).
Cizzle Biotechnology Stock Down 14.6%
The company has a market capitalization of £4.99 million, a PE ratio of -210.00 and a beta of 0.38. The company’s 50 day moving average is GBX 1.49 and its two-hundred day moving average is GBX 1.59.
About Cizzle Biotechnology
Cizzle Biotechnology Holdings Plc, together with its subsidiaries, engages in the development of an immunoassay test for the CIZ1B biomarker for the early detection of lung cancer in the United Kingdom. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021.
Recommended Stories
- Five stocks we like better than Cizzle Biotechnology
- Insider Trades May Not Tell You What You Think
- Union Pacific: Laying the Tracks for America’s Industrial Renewal
- Stock Sentiment Analysis: How it Works
- TransDigm’s Edge: From Spare Parts to Sky-High Profits
- Stock Average Calculator
- Spire Global: Tiny Satellites, Big Buy Ratings and Upside
Receive News & Ratings for Cizzle Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cizzle Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.
